LLY

956.19

-1.64%↓

JNJ

221.61

-0.09%↓

ABBV

200.92

-1.19%↓

UNH

373.87

+1.76%↑

AZN

182.54

+0.47%↑

LLY

956.19

-1.64%↓

JNJ

221.61

-0.09%↓

ABBV

200.92

-1.19%↓

UNH

373.87

+1.76%↑

AZN

182.54

+0.47%↑

LLY

956.19

-1.64%↓

JNJ

221.61

-0.09%↓

ABBV

200.92

-1.19%↓

UNH

373.87

+1.76%↑

AZN

182.54

+0.47%↑

LLY

956.19

-1.64%↓

JNJ

221.61

-0.09%↓

ABBV

200.92

-1.19%↓

UNH

373.87

+1.76%↑

AZN

182.54

+0.47%↑

LLY

956.19

-1.64%↓

JNJ

221.61

-0.09%↓

ABBV

200.92

-1.19%↓

UNH

373.87

+1.76%↑

AZN

182.54

+0.47%↑

Inicio・Lista de Acciones・Stevanato Group SpA

Stevanato Group SpA

Abierto

SectorSanidad

17.97 -1.16

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

17.75

Máximo

18.62

Métricas clave
By Trading Economics
Ingresos	-2M 47M
Ventas	40M 343M
P/B Media del Sector	29.65 49.8
Margen de beneficios	13.738
Empleados	6,010
EBITDA	18M 90M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+35.88% upside

Dividendos
By Dow Jones
Próximas Ganancias	4 ago 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	737M 4.9B
Apertura anterior	19.13
Cierre anterior	17.97

Noticias sobre sentimiento de mercado

By Acuity

50%

166 / 347 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

21.56 / 22.61 Soporte y Resistencia

Stevanato Group SpA Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

7 may 2026, 23:58 UTC

Ganancias

OCBC's First-Quarter Net Profit Rose on Record Noninterest Income

7 may 2026, 22:57 UTC

Ganancias

Australia's Macquarie Beats Consensus With 30% Fiscal Year Profit Jump

7 may 2026, 23:52 UTC

Ganancias

CoreWeave Stock Dives on Weak Outlook -- Barrons.com

7 may 2026, 23:45 UTC

Charlas de Mercado

Nikkei May Decline Amid Middle East Uncertainty -- Market Talk

7 may 2026, 23:39 UTC

Charlas de Mercado

Gold Rises on Signs of Ongoing U.S.-Iran Tensions -- Market Talk

7 may 2026, 23:28 UTC

Charlas de Mercado

Australian Budget Set to Contain A$64B in Spending Cuts-- Market Talk

7 may 2026, 23:11 UTC

Ganancias

OCBC Group CEO: Well-Positioned to Navigate Uncertainties, Deliver Sustainable Long-Term Value >O39.SG

7 may 2026, 23:06 UTC

Ganancias

Oversea-Chinese Banking Corp. 1Q Net Interest Margin 1.76%, Down 28 Bps on Year >O39.SG

7 may 2026, 23:05 UTC

Ganancias

Oversea-Chinese Banking Corp.: Solid 1Q Performance Underpinned by Record Non-Interest Income >O39.SG

7 may 2026, 23:04 UTC

Ganancias

Oversea-Chinese Banking Corp. 1Q Non-Interest Income S$1.61B Vs. S$1.31B >O39.SG

7 may 2026, 23:03 UTC

Ganancias

Oversea-Chinese Banking Corp. 1Q Net Interest Income S$2.22B Vs. S$2.35B >O39.SG

7 may 2026, 23:03 UTC

Ganancias

Oversea-Chinese Banking Corp. 1Q Net S$1.97B Vs. Net S$1.88B >O39.SG

7 may 2026, 23:02 UTC

Ganancias

Oversea-Chinese Banking Corp. 1Q Total Income S$3.83B Vs. S$3.66B >O39.SG

7 may 2026, 23:00 UTC

Charlas de Mercado

Australia's Federal Budget Likely to Contain Significant Reforms -- Market Talk

7 may 2026, 22:45 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

7 may 2026, 22:45 UTC

Charlas de Mercado

Lyft Says Efforts to Service Waymo's AVs Are Underway -- Market Talk

7 may 2026, 22:42 UTC

Ganancias

Australia's Macquarie Beats Consensus With 30% FY Profit Jump

7 may 2026, 22:33 UTC

Ganancias

Adquisiciones, fusiones, absorciones

Gilead Stock Falls. A Massive Acquisition Spree Is Coming at a Cost. -- Barrons.com

7 may 2026, 22:32 UTC

Ganancias

Macquarie FY Total Customer Deposits A$221.5B Vs. A$177.7B>MQG.AU

7 may 2026, 22:31 UTC

Ganancias

Macquarie FY Return on Equity 14.0% Vs. 11.2%>MQG.AU

7 may 2026, 22:31 UTC

Ganancias

Macquarie: 68% of FY Income From International >MQG.AU

7 may 2026, 22:30 UTC

Ganancias

Macquarie Bank Year-End CET1 Level 2 Ratio 12.8%>MQG.AU

7 may 2026, 22:30 UTC

Ganancias

Macquarie Capital Surplus A$9.3B at March 31 Vs. A$9.5B a Year Earlier>MQG.AU

7 may 2026, 22:29 UTC

Ganancias

Macquarie CEO: Well-Positioned for Superior Medium-Term Performance>MQG.AU

7 may 2026, 22:28 UTC

Ganancias

Macquarie: Continues a Conservative Approach to Capital, Funding, Liquidity>MQG.AU

7 may 2026, 22:28 UTC

Ganancias

Macquarie: Continues to Maintain a Cautious Stance>MQG.AU

7 may 2026, 22:27 UTC

Ganancias

Macquarie: Decision Recognizes Prevailing Market Conditions>MQG.AU

7 may 2026, 22:27 UTC

Ganancias

Macquarie Has Not Purchased Shares Since Extending the Buyback>MQG.AU

7 may 2026, 22:26 UTC

Ganancias

Macquarie to End Share Buyback Extended in November>MQG.AU

7 may 2026, 22:25 UTC

Ganancias

Macquarie Commodities and Global Markets FY Net Profit Contribution A$4.2B, Up 49% on Year>MQG.AU

Comparación entre iguales

Cambio de precio

Stevanato Group SpA previsión

Precio Objetivo

By TipRanks

35.88% repunte

Estimación a 12 Meses

Media 24.5 USD 35.88%

Máximo 32 USD

Mínimo 17.5 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Stevanato Group SpA Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

6 ratings

Comprar

Mantener

Vender

De acuerdo con 6 analistas que ofrecen calificaciones bursátiles a para Stevanato Group SpA Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

21.56 / 22.61Soporte y Resistencia

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Sentimiento

By Acuity

166 / 347 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.